Marshall Wace’s NanoViricides NNVC Stock Holding History

Marshall Wace’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,037	Closed	-$51K	–	4163
2021 Q3	$51K	Buy	+11,037	New	+$46K	﹤0.01%	2935

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Marshall Wace's NNVC Position: Q4 2021 in Review

Marshall Wace sold out of NanoViricides (NNVC) in Q4 2021, closing a stake of 11,037 shares — an estimated $51K sold.

Marshall Wace first reported a position in NNVC in Q3 2021 and held it in 1 quarter. The position peaked at $51K in Q3 2021. 29 funds tracked by Wall St. Rank hold NNVC as of Q4 2021.

Marshall Wace reported no remaining NanoViricides position as of Q4 2021 after selling out during the quarter.
Marshall Wace sold 11,037 NanoViricides shares in Q4 2021, an estimated $51K.
Marshall Wace first reported a position in NanoViricides in Q3 2021 and held it in 1 quarter.
Marshall Wace's NanoViricides position peaked at $51K in Q3 2021.
29 funds tracked by Wall St. Rank held NanoViricides as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.